Abstract
Compared to the wide range of antibiotics that are available, the number of antiviral drugs is limited. However, herpesviruses have always been a major target for antiviral drug design, and there are a wide range of drugs at various stages of development. All of the assays described in this chapter provide relatively simple methods for plaque reduction assay of herpesviruses. Clearly, it is not possible to perform such assays on those herpesviruses that do not grow in adherent cells, such as Epstein-Barr virus. These require a different approach and are discussed elsewhere in this volume.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Welsh, M. D. (1991) Studies on the neutralisation of VZV by two specific monoclonal antibodies. Honours thesis, Queens University of Belfast, Belfast, UK.
Grose, C. and Brunel, P. A. (1978) Varicella-zoster virus: isolation and propagation in human melanoma cells at 36 and 32 degrees C. Infect. Immun. 19, 199–203.
Harper, D. R., Gilbert, R. L., O’Connor, T. J., Kinchington, D., Mahmood, N., McIlhinney, R. A. J., and Jeffries, D. J. (1996) Antiviral activity of 2-hydroxy fatty acids. Antivir. Chem. Chemother. 7, 138–141.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Harper, D.R. (2000). Determination of Viral Infectivity. In: Kinchington, D., Schinazi, R.F. (eds) Antiviral Methods and Protocols. Methods in Molecular Medicine™, vol 24. Humana Press. https://doi.org/10.1385/1-59259-245-7:119
Download citation
DOI: https://doi.org/10.1385/1-59259-245-7:119
Publisher Name: Humana Press
Print ISBN: 978-0-89603-561-4
Online ISBN: 978-1-59259-245-6
eBook Packages: Springer Protocols